ID   PET
AC   CVCL_N816
DR   Cosmic; 1656048
DR   Wikidata; Q54947229
RX   PubMed=15274292;
RX   PubMed=22426987;
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C9350; Peritoneal malignant mesothelioma
DI   ORDO; Orphanet_168811; Malignant peritoneal mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
RX   PubMed=15274292;
RA   Li Q., Verschraegen C.F., Mendoza J.T., Hassan R.;
RT   "Cytotoxic activity of the recombinant anti-mesothelin immunotoxin,
RT   SS1(dsFv)PE38, towards tumor cell lines established from ascites of
RT   patients with peritoneal mesotheliomas.";
RL   Anticancer Res. 24:1327-1335(2004).
//
RX   PubMed=22426987; DOI=10.3892/or.2012.1725;
RA   Kalra N., Ashai A., Xi L.-Q., Zhang J.-L., Avital I., Raffeld M.,
RA   Hassan R.;
RT   "Patients with peritoneal mesothelioma lack epidermal growth factor
RT   receptor tyrosine kinase mutations that would make them sensitive to
RT   tyrosine kinase inhibitors.";
RL   Oncol. Rep. 27:1794-1800(2012).
//